Colorado Blood Cancer Institute/SCRI — Denver, Colorado

Colorado Blood Cancer Institute/SCRI is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Colorado Blood Cancer Institute/SCRI has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Relapsed/Refractory Systemic Light Chain Amyloidosis, Multiple Myeloma.

Sponsors: Regeneron Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Denver

Browse all research sites in Colorado · View every site in Denver

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Colorado Blood Cancer Institute/SCRI?

Colorado Blood Cancer Institute/SCRI has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Colorado Blood Cancer Institute/SCRI conducted?

Colorado Blood Cancer Institute/SCRI has 2 clinical trials on record, with 2 currently active. Their work covers Relapsed/Refractory Systemic Light Chain Amyloidosis, Multiple Myeloma.

Is Colorado Blood Cancer Institute/SCRI accredited by Crixeo Clinical Trials?

Colorado Blood Cancer Institute/SCRI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Colorado Blood Cancer Institute/SCRI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.